Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ESSENTIALIS, INC.”

16 pharma patents match "ESSENTIALIS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 16
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 16 pharmaceutical patents matching "ESSENTIALIS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

16 results for “ESSENTIALIS, INC.” · 30,257 patents in full index Clear search

  1. US 12419895

    Methods for treating subjects with Prader-Willi syndrome

    ESSENTIALIS, INC. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12343348

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  3. US 12178823

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  4. US 12109216

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  5. US 11786536

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  6. US 11045478

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  7. US 10874676

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  8. US 10456408

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  9. US 10085998

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  10. US 10058557

    Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome

    ESSENTIALIS, INC. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted
  11. US 9782416

    Pharmaceutical formulations of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  12. US 9765043

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  13. US 9757384

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  14. US 9381202

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  15. US 7799777

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Sep 21, 2010 · Expires Sep 16, 2030

    granted
  16. US 7572789

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted